Pulmonary Health Center (BKPM), Maluku-Indonesia, Indonesia
Background and Aims: Indonesia is one of the 27 MDR-TB high burden countries worldwide, with estimated 6,800 new cases every year. In Maluku, although there is no data on MDR TB cases but suspected cases of MDR TB already exist and there are increasing number of suspected MDR-TB at pulmonary health centre in Maluku. The aim of this study is to know the knowledge, attitude and behaviour of patient suspect MDR-TB in BKPM Maluku.
Methods:
We used cross sectional study with accidental sampling method from January 2010 to December 2012 at BKPM Maluku-Indonesia with total sampling was 50 patients.
Results:
The study included 29 (58%) males and 21 (42%) females with highest education backgrounds was senior high school 29 (58%). There were twenty-six (52%) patients have the monthly income salary less than USD74. Half of them (58%) had normal IMT. There were 6 (12.5%) patients with DM, and 17 (34%) patients were alcoholic or smokers. Moreover, there were 13 (26%) patients had received the injection TB drug program.
Patients were diagnosed with suspected MDR-TB (62%) having less knowledge about TB and mostly do not know the aetiology of TB and MDR-TB as well.
Thirty respondents (60%) had the moderate attitude about TB. Most of them had followed the recommendation to take regular TB medication 38 (76%). Unfortunately, they dropped out from the treatment program. Only 4 (8%) patients adhered the standard TB treatment. Regarding the attitude of coughing, side effects and quitting smoking/alcohol, there were 1 (2%), 1 (2%), 1 (2%) patients had better attitude respectively.
Conclusion:
The lack of knowledge about the causes of TB and MDR-TB is the greatest finding that affected the attitude and behaviour of TB patients. Background and Aims: Despite wide use of interferon-gamma releasing assay for the diagnosis of latent tuberculosis infection (LTBI), the initiation rate of and factors associated with LTBI treatment among health care workers (HCWs) have not been well elucidated. The aim of this study was to evaluate the initiation rate of LTBI treatment and find factors associated with non-initiation of LTBI treatment among HCWs.
Methods:
A cross-sectional study of 293 HCWs with LTBI was performed in a teaching hospital in Korea. LTBI was diagnosed with QuantiFERON-TB Gold In-Tube tests (Cellestis Ltd., Carnegie, VIC, Australia).
Results: Of the 293 HCWs with LTBI, 189 HCWs (64.5%) visited outpatient department to receive medical consultation for LTBI treatment. Of these, 128 subjects (67.7%) agreed with LTBI treatment with an overall 43.6% of LTBI treatment initiation rate. In multivariate analysis, being physicians (adjusted odds ratio [OR] = 12.87, 95% confidence interval [CI] = 2.78-59.54) and years of employment ≥ 20 years (adjusted OR = 4.54, 95% CI = 1.76-11.74) were independent factors associated with non-initiation of LTBI treatment. Among the subjects who visited outpatient department, those with the years of employments ≥ 20 years (adjusted OR = 7.05, 95% CI = 1.59-31.31) and having chronic liver diseases or taking potential hepatotoxic drugs (adjusted OR = 10.51, 95% CI = 2.15-51.36) were independently associated with refusal of LTBI treatment.
Conclusion:
The overall initiation rate of LTBI treatment was suboptimal in HCWs with LTBI diagnosed with interferon-gamma releasing assay. An augmented LTBI treatment strategies which can improve the participation rate of medical consultation and encouraging acceptance rate of LTBI treatment are needed to effectively control LTBI in HCWs. 
